Cosmo N.V. (SWX:COPN)

Switzerland flag Switzerland · Delayed Price · Currency is CHF
93.20
-0.30 (-0.32%)
Apr 23, 2026, 12:47 PM CET
Market Cap1.51B +71.9%
Revenue (ttm)96.99M -61.0%
Net Income-3.36M
EPS-0.21
Shares Out16.19M
PE Ration/a
Forward PE1,348.39
Dividend1.93 (2.06%)
Ex-Dividend DateApr 24, 2026
Volume13,908
Average Volume58,558
Open92.90
Previous Close93.50
Day's Range92.00 - 97.00
52-Week Range41.60 - 129.40
Beta1.55
RSI50.22
Earnings DateJul 20, 2026

About Cosmo

Cosmo N.V., a life sciences company, develops and manufactures pharmaceuticals and contracts for gastroenterology, dermatology, and health tech in Ireland and internationally. The company offers GI Genius, a computer-assisted system that uses artificial intelligence in real time to detect colorectal lesions; Winlevi, a prescription medicine used on the skin to treat acne vulgaris; Lialda/Mezavant/Mesavancol, a once-daily mesalamine tablet approved to help get active, mild to moderate ulcerative colitis into remission; Uceris/Cortiment, an oral ... [Read more]

Sector Healthcare
Founded 1997
Employees 325
Stock Exchange SIX Swiss Exchange
Ticker Symbol COPN
Full Company Profile

Financial Performance

Financial numbers in EUR Financial Statements